Volume 45, Issue 9

Search all European Journal of Nuclear Medicine and Molecular Imaging articles

July 2018

Topical Issue on Brain Imaging / Including the Special Section: Diagnostic Utility of FDG-PET in Dementia: Literature Evidence and Expert Opinion

Issue Editors:

Flavio Nobili,
Reinhold Schmidt,
Giovanni B. Frisoni

17 articles in this issue

Brain FDG-PET: clinical use in dementing neurodegenerative conditions
Flavio Nobili
Reinhold Schmidt
Giovanni B. Frisoni
Editorial 23 April 2018 Pages: 1467 - 1469
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia
Marina Boccardi
Cristina Festari
for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders
Review Article 30 April 2018 Pages: 1470 - 1486
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease
Alexander Drzezga
Daniele Altomare
for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders
Review Article 13 May 2018 Pages: 1487 - 1496
Clinical utility of FDG-PET for the clinical diagnosis in MCI
Javier Arbizu
Cristina Festari
for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders
Review Article 27 April 2018 Pages: 1497 - 1508
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia
Peter J. Nestor
Daniele Altomare
for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders
Guidelines 07 May 2018 Pages: 1509 - 1525
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia
Femke Bouwman
Stefania Orini
for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders
Guidelines Open access 09 May 2018 Pages: 1526 - 1533
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
Zuzana Walker
Federica Gandolfo
for the EANM-EAN Task Force for the recommendation of FDG PET for Dementing Neurodegenerative Disorders
Review Article Open access 19 May 2018 Pages: 1534 - 1545
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease
Federica Agosta
Daniele Altomare
for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders
Original Article 01 May 2018 Pages: 1546 - 1556
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders
Flavio Nobili
Cristina Festari
For the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders
Review Article 02 May 2018 Pages: 1557 - 1566
¹⁸F-FDG PET and high-resolution MRI co-registration for pre-surgical evaluation of patients with conventional MRI-negative refractory extra-temporal lobe epilepsy
Yao Ding
Yuankai Zhu
Mei Tian
Short Communication 18 April 2018 Pages: 1567 - 1572
Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas
Manuel Röhrich
Kristin Huang
Uwe Haberkorn
Original Article 07 May 2018 Pages: 1573 - 1584
The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage
Han Soo Yoo
Seok Jong Chung
Phil Hyu Lee
Original Article 04 May 2018 Pages: 1585 - 1595
Quantitative evaluation of tau PET tracers ¹⁸F-THK5351 and ¹⁸F-AV-1451 in Alzheimer’s disease with standardized uptake value peak-alignment (SUVP) normalization
Jingyun Chen
Yi Li
Alzheimer’s Disease Neuroimaging Initiative
Original Article 27 April 2018 Pages: 1596 - 1604
Dual tracer tau PET imaging reveals different molecular targets for ¹¹C-THK5351 and ¹¹C-PBB3 in the Alzheimer brain
Konstantinos Chiotis
Per Stenkrona
Agneta Nordberg
Original Article Open access 12 May 2018 Pages: 1605 - 1617
Noradrenaline transporter availability on [¹¹C]MRB PET predicts weight loss success in highly obese adults
Franziska J. Vettermann
Michael Rullmann
Swen Hesse
Original Article 07 April 2018 Pages: 1618 - 1625
Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience
Garry Ceccon
Lazaros Lazaridis
Norbert Galldiks
Original Article 21 March 2018 Pages: 1626 - 1635
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with ²¹³Bi-substance P analogue
Leszek Krolicki
Frank Bruchertseifer
Alfred Morgenstern
Original Article Open access 30 April 2018 Pages: 1636 - 1644

Volume 45, Issue 9

Search

Navigation